Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.84

+1.8%

Dec 19 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: former_pgs who wrote (14727)	12/17/2004 1:34:11 PM
From: zeta1961	Read Replies (3) of 52153

<<My bet is that the 800 mg dose is causing problems.>> I agree with you...the study showing no cardiac problems was done with 400mg/day..the 400-800mg showed the issues.. The caveat, imo, is eventhough the majority of patients taking it for pain(200mg is on the label, I believe) there are numerous studies using it for cancer treatment at 400-800mg/day with aggressive cancers getting 800mg..and also physicians prescribing it off label, outside of controlled clinical trials, in this population.. Zeta

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next